92638 ⎘
Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
Sub-classes:(4R)-3-(4-FLUORO-2-HYDROXYPHENYL)-4-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXIMIDAMIDE HYDROCHLORIDE AND DERMAL FORMULATIONS THEREOF
#2DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORS
#3NOVEL CURCUMIN DERIVATIVE WITH ENHANCED ANTIOXIDANT PROPERTIES
#4DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORS
#5NOVEL METHODS FOR SYNTHESIZING ENANTIOPURE (S)-METHADONE, (R)-METHADONE, RACEMIC (R,S)-METHADONE AND RELATED ANALOGUE SUBSTANCES
#6CONJUGATED DIYNES AND THEIR USE AS FLAVOR MODIFIERS
#7Alkoxy compounds for disease treatment
#8FORMAMIDE MONOMERS AND POLYMERS SYNTHESIZED THEREFROM
#9Dimethoxyphenylalkylamine activators of serotonin receptors
#10Inhibitors of the n-terminal domain of the androgen receptor
#11STRUCTURALLY MODIFIED OPIOIDS FOR PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS
#12Alkoxy compounds for disease treatment
#13Functionalized N,N-dialkylamino phenyl ethers and their method of use
#14Formamide monomers and polymers synthesized therefrom
#15Glucose-6-Phosphate Dehydrogenase (G6PD)-Modulating Agents And Methods Of Treating G6PD Deficiency
#16Inhibitors of the N-terminal domain of the androgen receptor
#17Compounds and methods for hematopoietic regeneration
#18NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES
#19Alkoxy compounds for disease treatment
#20SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF
#21Monoamine reuptake inhibitors
#22Alkoxy compounds for disease treatment
#23Enamine compounds for absorbance of electromagnetic energy
#24PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#25Process for the Preparation of N-Monosubstituted beta-Amino Alcohols
#26A NOVEL PROCESS FOR CHIRAL RESOLUTION OF HIGHLY PURE (6R)-6-(DIMETHYLAMINO)-4,4-DIPHENYL-HEPTANONE FROM RACEMIC METHADONE HYDROCHLORIDE
#27Compositions comprising a polymeric network
#28Pentadienoyl piperidine derivative and use thereof
#29PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#30HIF inhibitors and use thereof
#31Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
#32Alkoxy compounds for disease treatment
#33Process for the preparation of key intermediates of omarigliptin
#34Photoinitiators
#353,4,5-trimethoxystyrylarylaminopropenones as potential anticancer agents
#36Antibacterial and antifungal biphenylyl compounds
#37Alkoxy compounds for disease treatment
#38Modified release formulations of a bupropion salt
#39Curcumin analogs
#40Process for the Preparation of N-Monosubstituted beta-Amino Alcohols
#41Photoinitiators
#42Process for the preparation of optically pure fesoterodine derivatives
#43Pharmaceutical compounds
#44HIF inhibitors and use thereof
#45CFO-containing enaminoketones and their utilization for the preparation of CFO-containing pyrazoles
#46()-6-(dimethylamino)-4,4-diphenylheptan-3-one
#47Catecholamine derivatives for obesity and neurological disorders
#48ANTIBACTERIAL AND ANTIFUNGAL SUBSTANCES BIPHENYLYL COMPOUNDS
#49Amine derivative compounds for treating ophthalmic diseases and disorders
#50Method of preparing chiral ketones from aldehydes
#51Multi-branched mannich base corrosion inhibitor and preparation method thereof
#52Phenalene-1-one derivatives, method for producing same and use thereof
#53Deuterium-enriched bupropion
#54Process for the preparation of N-monosubstituted β-amino alcohols
#55Photoinitiators
#56Polymeric photoinitiators
#57Alkoxy compounds for disease treatment
#58Process for the synthesis of tapentadol and intermediates thereof
#59Plant activator
#60Process for preparing benzofuran derivatives substituted at position 5
#61Bupropion hydrobromide polymorphs
#62Ketobenzofuran derivatives, method for synthesizing same, and intermediates
#63Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
#64Compounds for binding and imaging amyloid plaques and their use
#65Process for the preparation of tapentadol and intermediates thereof
#66Alkoxy compounds for disease treatment
#67Alkoxy compounds for disease treatment
#68Alkoxy compounds for disease treatment
#69FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#70Monoamine reuptake inhibitors
#71HIF inhibitors and use thereof
#72Amine derivative compounds for treating ophthalmic diseases and disorders
#73Amine derivative compounds for treating ophthalmic diseases and disorders
#74S1P receptors modulators
#75CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS
#76PROCESS FOR PREPARING CINACALCET HYDROCHLORIDE
#77Process for preparing Cinacalcet
#78Deuterium-enriched bupropion
#79Amorphous bupropion hydrobromide and preparation thereof
#80PHOTORESIST COMPOSITION
#81Process for the preparation of -monosubstituted β-amino alcohols
#82Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
#83Process for the preparation of N-monosubstituted beta-amino alcohols
#84Modified-release formulations of a bupropion salt
#85Method for the determination of an analyte comprising a primary amino group, and kit for labeling said analyte
#86Bupropion Metabolites and Methods of Their Synthesis and Use
#87METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE
#88Process for Production of Optically Active Benzylamine Derivatives
#89Bupropion hydrobromide polymorphs
#90Agent for dyeing keratin-containing fibers
#91Methadone chiral isolate as an improved pharmaceutical
#92Alkoxy compounds for disease treatment
#93N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
#94Amine derivative compounds for treating ophthalmic diseases and disorders
#95Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
#96Amino alcohol derivatives, salts thereof and immunosuppresive agents
#97CLASS OF ORGANIC COMPOUNDS CONTAINING HETEROATOM AND ITS APPLICATIONS IN PREPARING SINGLE-SITE ZIEGLER-NATTA CATALYST
#98Process for preparing R-gossypol L-phenylalaninol dienamine
#992-aminobutanol compound and use thereof for medical purposes
#100DEUTERIUM-ENRICHED BUPROPION
#101Process for preparing bupropion hydrochloride
#102Compounds and related methods for mutant p53 reactivation
#103Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
#104Process for the preparation of N-monosubstituted beta-amino alcohols
#105Modified release formulations of a bupropion salt
#106Substituted enaminones, their derivatives and uses thereof
#107Modified release formulations of a bupropion salt
#108Modified release formulations of a bupropion salt
#109Modified release formulations of a bupropion salt
#110Modified release formulations of a bupropion salt
#111Modified release formulations of a bupropion salt
#112Modified release formulations of a bupropion salt
#113Modified release formulations of a bupropion salt
#114Quaternary Amino-Function Chalcones
#115Modified release formulations of a bupropion salt
#116MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
#117Modified release formulations of a bupropion salt
#118Modified release formulations of a bupropion salt
#119Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates
#120N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
#121Modified release formulations of a bupropion salt
#122Clear photopolymerizable systems for the preparation of high thickness coatings
#123Diamino-functional chalcones
#124Calcium receptor-active molecules
#125Amino-propanol derivatives
#126Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates
#127Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives
#128Amino alcohol derivative, addition salt thereof, and immunosuppressant
#129Method for the production of monoalkylamino ketones
#130Intermediates of bupropion metabolites synthesis
#131Amino-functional chalcones
#132Intermediate products, methods for their preparation and use thereof
#133N-(2-Arylethyl) benzylamines as antagonists of the 5-HTreceptor
#134Process for producing optically active β-amino alcohol
#135Ketones
#136Process for the preparation of n-monosubstituted beta-amino alcohols
#137Compounds and related methods for mutant p53 reactivation
#138Aminoalkoxy-functional chalcones
#139Narcotic-NSAID ion pairs
#140Beta-amino ketones for the treatment of pain